Tempus, Intermountain to collaborate on oncology research

2019 05 22 19 44 5254 Dna Red Laser 400

Artificial intelligence (AI) developer Tempus and Intermountain Healthcare plan to collaborate on oncology research using genomic testing and data analytics.

Intermountain will use Tempus's solid tumor/normal genomic test, xT, to generate RNA data from existing transcriptomic samples; the RNA data will be matched with DNA data and used for oncology research, according to Tempus.

Page 1 of 17
Next Page